Medical Decision Making among Individuals with a Variant of Uncertain Significance in a Hereditary Cancer Gene and those with a CHEK2 Pathogenic Variant
Despite national guidelines, women with a BRCA VUS or CHEK2 pathogenic variant are choosing to have risk-reducing surgeries such as bilateral mastectomies which are not aligned with their level of cancer risk based on genetic test results alone. Semi-structured telephone interviews were conducted wi...
Main Author: | Almanza, Deanna J. |
---|---|
Format: | Others |
Published: |
Scholar Commons
2019
|
Subjects: | |
Online Access: | https://scholarcommons.usf.edu/etd/7726 https://scholarcommons.usf.edu/cgi/viewcontent.cgi?article=8923&context=etd |
Similar Items
-
Germline Mutations in CHEK1 and CHEK2 in Women with Ovarian, Peritoneal, or Fallopian Tube Cancer
by: Harrell, Maria Isabel
Published: (2015) -
Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years
by: Christos Petridis, et al.
Published: (2019-05-01) -
The Screen Project: Guided Direct-To-Consumer Genetic Testing for Breast Cancer Susceptibility in Canada
by: Steven A. Narod, et al.
Published: (2021-04-01) -
THE IMPACT OF GENETIC COUNSELING ON CLINICAL DECISION MAKING AMONG WOMEN EVALUATED FOR HEREDITARY BREAST AND OVARIAN CANCER RISK
by: PRITZLAFF, MARY ELIZABETH
Published: (2001) -
Contribution of the Defective <it>BRCA1</it>, <it>BRCA2 </it>and <it>CHEK2 </it>Genes to the Familial Aggregation of Breast Cancer: a Simulation Study Based on the Swedish Family-Cancer Database
by: Bermejo Justo, et al.
Published: (2004-11-01)